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heparin is thought to reduce these effects. Heparin-
bonded systems indeed improve clinical outcomes,8 by
preventing complement and contact activation,9,10 and
platelet adhesion.11 They do not prevent platelet activa-
tion, however.12,13 This indicates that platelets might
also be activated by other factors than blood-material
contact and in this way cause vascular problems. In a
recent study with rat and human blood, we demonstrat-
ed that platelets in albumin-coated extracorporeal sys-
tems can be activated by elevated shear stress caused by
the pump.14 The goal of the present study was to sepa-
rate the effects of pump and blood-material contact and
to investigate whether both can induce hypotension and
edema. We also studied whether these effects can be
prevented by coating the system with albumin and by
blocking pump-induced platelet aggregation. Albumin
was used instead of heparin to avoid possible direct
effects of surface-bound heparin on platelets. Moreover,
it has been reported to be as effective as heparin coating
in preventing platelet aggregation and activation caused
by blood-material contact.11,15
U se of extracorporeal systems in cardiopulmonarybypass and dialysis may induce serious vascular
derangements, such as hypotension and edema.1-4 This
may be an effect of blood-material contact activating
the complement system, the contact system, and blood
platelets, with release of agents that lead to vasodilation
and vascular leakage, such as bradykinin,5 histamine,5
and serotonin.5-7 Coating the foreign material with
Objective: Use of extracorporeal systems in cardiopulmonary bypass and
dialysis induces vascular reactions, which can lead to hypotension and lung
edema.
Methods: To study the contribution of blood-material contact and use of a
roller pump, as well as prevention of their adverse effects, we perfused a rat
hind leg with a tube connecting a carotid and a femoral artery.
Results: Autoperfusion of an uncoated tube caused a fall of aortic pressure
and femoral resistance to 66% ± 16% and 76% ± 15%, respectively, of their
initial values within 2 hours, whereas in control animals without a shunt,
these variables hardly changed (to 94% ± 2.8% and 99% ± 2.8%, respec-
tively). Lung water content became significantly higher than that found in
control animals (79.4% ± 1.50% versus 77.0% ± 1.67%). If we coated the
tube with albumin, these changes were largely prevented. When the coated
tube was placed in a roller pump, aortic pressure and femoral resistance
immediately fell to 79% ± 17.2% and 63% ± 13.5%, respectively, whereas
lung water content did not increase. The vasodilation was caused by platelet
aggregation and could be prevented with aurintricarboxylic acid, which
inhibits shear-induced platelet aggregation by blocking the binding of von
Willebrand factor to platelet glycoprotein Ib receptors.
Conclusions: Extracorporeal circulation may induce hypotension and lung
edema by means of blood-material contact. Hypotension can be prevented by
coating the system with albumin but can still result from pump-induced
platelet aggregation. (J Thorac Cardiovasc Surg 2000;120:12-9)
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Methods
Male Wistar rats (335-410 g) were anesthetized with an
intramuscular bolus of ketamine (10%, 60 mg/kg; Kombivet)
and a subsequent intraperitoneal injection of pentobarbital
(Nembutal, 35 mg/kg). Thereafter, pentobarbital was contin-
uously infused at 10 to 14 mg/kg per hour. After tracheotomy,
the animals were ventilated with a mixture of room air and
oxygen (3:1) at 90 breaths/min. Tidal volume was adjusted so
that a capnometer (Datex Normocap D-102, Helsinki,
Finland) indicated an end-expiratory carbon dioxide content
of 5%, corresponding with an arterial PCO2 of approximately
40 mm Hg. Mean arterial pH and PO2 ranged from 7.32 to
7.45 and from 76 to 132 mm Hg, respectively. Body temper-
ature was kept at 37.5°C by using a servo-controlled heating
device. All handling of the animals was in compliance with
the “Guide for the Care and Use of Laboratory Animals”
(National Institutes of Health publication No. 85-23, revised
1985).
The rats were heparinized intravenously with 800 IU/kg
(Leo Pharmaceutical Products BV, Weesp, The Netherlands).
After cannulation of the central part of a carotid (20-gauge
cannula) and distal part of the left femoral artery (22-gauge
cannula), the cannulas were interconnected with new medical
grade polyvinyl chloride tubing (Fig 1). In the autoperfusion
experiments this tube (1.5 mm inner diameter) was 30 cm
long and filled with heparinized saline solution. During the
connection procedure, flow to the leg was interrupted for 2 to
3 minutes only. A warming lamp above the animal kept the
blood in the tube at 37°C ± 1°C. In the pump experiments the
tube had a length of 45 cm, and part of the tube was loosely
positioned in the roller pump. If the tube in the pump was not
compressed, blood flowed spontaneously (2-4 mL/min) as a
result of the pressure difference between the central carotid
and distal femoral artery. For transition to pump flow, the
tube was gradually compressed until flow stopped, and the
pump was then started and set to the spontaneous flow imme-
diately before institution of pump flow.
The whole system was either coated with albumin or not
coated. The method of coating has been described previous-
ly.16 Tests with radioactively labeled albumin showed that the
coating consisted of one to two monolayers and was stable
during at least 4 hours of blood perfusion.
Flow in the tubing was measured with a perivascular flow
probe (1RB; Transonic Systems Inc, Ithaca, NY). The mea-
surement was calibrated in vitro by using timed collection of
blood at 37°C. Aortic and femoral pressures were measured
with Statham P23 Db pressure transducers (Viggo
Spectramed, Inc, Critical Care Division, Oxnard, Calif) by
using stainless steel T pieces in the shunt at approximately 3
cm from the carotid cannula and just before the femoral can-
Fig 1. Extracorporeal shunt between carotid and femoral artery in the rat. Aortic (P
ao
) and femoral (Pfem) pres-
sures, flow, and platelet aggregation were measured at the positions indicated. During autoperfusion, the tube was
not compressed. By tightening the rollers and starting the pump, spontaneous flow could simply be replaced by
pump flow.
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nula. Femoral resistance was calculated from the ratio of
femoral pressure and flow.
Measurement of platelet behavior. In the pump experi-
ments possible platelet aggregation in the tube was continu-
ously measured with a photometric device by using the fact
that light transmission through flowing blood increases dur-
ing passage of platelet aggregates.17 Distal to the pump (Fig
1), the tube was serially connected to a 12-mm long albumin-
coated glass capillary (inner diameter 0.6 mm) on the stage of
a microscope. The image of this capillary was projected onto
an array of photosensitive cells, and passage of aggregates
was indicated by short-lasting voltage peaks. For quantitation
of aggregation, the signals were converted to uniform spikes
with a spike processor and subsequently counted over fixed
periods. The result was related to the value found after injec-
tion of 2 ng of adenosine diphosphate into the tube. This dose
was dissolved in 20 µL of saline solution and elicited, when
injected within half a second, strong aggregation that did not
impede flow.
For platelet counting and visual inspection of aggregates,
blood (0.1 mL) was withdrawn from the distal T piece and
added to 0.15 mL of ethylenediamine tetraacetic acid solution
(3.6 mg/mL saline solution), resulting in a final concentration
of 6.6 mmol/L to stabilize the aggregates. Then 0.02 mL was
added to 2 mL of Thromboplus solution and inspected in a
Bürker counting chamber under phase-contrast microscopy
(400×). Periodic comparison confirmed the results obtained
with the continuous aggregometer and indicated that with
that meter only aggregates were detected that consisted of 4
or more platelets. Platelets were counted with a Coulter
counter (model ZF; Coulter Electronics, Inc, Hialeah, Fla),
and the counts were corrected for hematocrit. For measure-
ment of hemolysis, 1 mL of arterial blood was withdrawn
before and after the experiment, and free hemoglobin in plas-
ma was determined by using a colorimetric method at 600 nm
(Sigma Chemical Company, St Louis, Mo; procedure No.
527).
Measurement of tissue water content. Edema formation
in the hind legs and lungs was studied by calculating the per-
centage of tissue water from the difference between wet and
dry weight. At the end of the experiment, approximately 1 g
of gastrocnemius muscle was removed and freed of blood by
gentle squeezing of the muscle with a paper tissue. The lungs
were inflated in situ, tied off, and then removed. Both tissues
were weighed, dried overnight at 60°C, and weighed again.
Control values of lung water content were derived from ani-
mals that were killed immediately after induction of anesthe-
sia; their hearts were used for other experiments.
Aurintricarboxylic acid. A trisodium salt of aurintricar-
boxylic acid (ATA; Aldrich Chemical Company, Bornem,
Belgium) was dissolved (30 mg/mL) in phosphate buffer (pH
= 7.4). A bolus of 35 mg/kg was infused intravenously with-
in 10 minutes in rats that had not been exposed to pump per-
fusion before. In a previous study17 this dose effectively
inhibited platelet aggregation in rats in which a mean shear
stress of 231 dynes/cm2 was generated by partial occlusion of
a tube between the carotid and femoral arteries.
Statistics. Values in the text and legends are expressed as
means ± SD, and those in the figures are expressed as means
± SEM. Time series data (Figs 2 and 3) were analyzed by
using 2-way analysis of variance for repeated measurements.
If the P value was smaller than .05, posttests for comparison
between conditions at different times were performed with
the Bonferroni multiple comparison procedure. Water content
data were analyzed with the Kruskal-Wallis test and posttest-
ed with the Dunn multiple comparison test. For comparison
between left and right leg data, the Wilcoxon matched pairs
test was used.
Results
Hypotensive effect of blood-material contact. In
animals not connected to an extracorporeal circuit
(group 1, n = 8), femoral resistance remained at base-
line level for 2 hours (Fig 2, squares), whereas aortic
pressure showed a small decrease to 94% ± 2.8% of its
initial value (P = .001). In animals with an uncoated
tube between the carotid and femoral arteries (group 2,
n = 9), femoral resistance and aortic pressure decreased
within 2 hours to 76% ± 15% and 66% ± 16.2% of their
initial values, respectively (Fig 2, diamonds). Coating
the tube with albumin (group 3, n = 9) largely prevent-
ed this: femoral resistance dropped to 96% ± 13.8%
only and aortic pressure to 87% ± 9% (Fig 2, circles).
Heart rate (381 ± 45 beats/min) did not change signifi-
cantly in any of the 3 groups.
Hypotensive effect of the pump. Start of pump per-
fusion in experiments with an albumin-coated tube
(group 4, n = 7) caused an immediate and significant
fall of femoral resistance and aortic pressure to 63% ±
13.5% and 79% ± 17.2% of their initial values, respec-
tively (Fig 3, diamonds). Thereafter, femoral resistance
slowly increased and stabilized at about 70% of its con-
trol value. Aortic pressure recovered within 20 minutes
to about 92% and then slightly decreased with a similar
amount as occurred in the absence of a pump (Fig 3, cir-
cles). Pumping had no significant effect on heart rate.
The decrease of femoral resistance by pump perfu-
sion must have been caused by vasodilation because
blood viscosity remained unaltered as judged from
hematocrit values: 49% ± 2.6% before and 50% ± 2.6%
after 2 hours of pumping.
Comparison of the hypotensive effects. The decline
of peripheral resistance and aortic pressure was gradual
when caused by blood-material contact but steep when
caused by pump perfusion. During the first 40 minutes,
peripheral resistance was significantly (P = .001) lower
during pump perfusion than during autoperfusion. For
aortic pressure, the difference was significant (P =
.006) at 5 minutes and again at 120 minutes.
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Edema formation. The upper panel of Fig 4 shows
that water content of the lungs was higher (P = .02)
after 2 hours of autoperfusion through an uncoated tube
(group 2, n = 8, 79.4% ± 1.50%) than without a tube
(group 6, n = 10, 77.0% ± 1.67%). By contrast, use of
a pump with a coated tube (group 4, n = 4) did not seem
to increase lung water content. The lower panel of Fig
4 shows that the water content of the gastrocnemius
muscle of the left leg did not exceed that of the right
noncannulated leg whether it was autoperfused with an
uncoated tube or pump-perfused with a coated tube.
The values were actually always somewhat lower in the
left than in the right leg (13 pairs, P = .001).
Platelet aggregation during pumping. Since the
start of pump perfusion had an immediate vasodilatory
and hypotensive effect, we evaluated whether this could
have been caused by activation of platelets. As long as
the coated tube was not compressed and blood flowed
freely from the carotid to the femoral artery, no platelet
aggregation was observed (Fig 5, left panel). However,
the start of the pump instantaneously elicited platelet
Fig 2. Time course of cardiovascular variables (means ±
SEM) during autoperfusion (no tube [n = 8]: open squares,
dotted line; uncoated tube [n = 9]: filled diamonds, solid line;
coated tube [n = 9]: filled circles, dashed line). Initial values
(means ± SD at time 0) were as follows: femoral resistance of
60 ± 9.3 (open squares), 71 ± 13 (filled diamonds), and 68 ±
10.3 mm Hg · min · mL–1 (filled circles); femoral flow of 2.38
± 0.32 (open squares), 2.03 ± 0.43 (filled diamonds), and
2.08 ± 0.44 mL/min (filled circles); and aortic pressure of 146
± 7.6 (open squares), 135 ± 10.5 (filled diamonds), and 135
± 13.5 mm Hg (filled circles). Plus signs and asterisks indi-
cate significant difference for uncoated (filled diamonds) ver-
sus control (open squares) and for uncoated (filled diamonds)
versus coated (filled circles), respectively.
Fig 3. Time course of cardiovascular variables (means ±
SEM) after onset of pump perfusion in an albumin-coated
tube without (filled diamond, solid line, n = 7) and with (open
squares, dotted line, n = 7) ATA. Pump flow was set equal to
spontaneous flow. Results with autoperfusion in the coated
tube (filled circles, dashed line, n = 9) are the same as in Fig
2 and shown for comparison. Initial values (means ± SD at
time 0) were as follows: femoral resistance of 71 ± 13.5
(filled diamonds), 123 ± 19.3 (open squares), and 68 ± 10.3
mm Hg · min · mL–1 (filled circles); and aortic pressure of 
124 ± 9.8 (filled diamonds), 132 ± 15.3 (open squares), and 
135 ± 13.5 mm Hg (filled circles). Plus signs indicate signifi-
cant difference between pump without ATA (filled diamonds)
and autoperfusion (filled circles). Asterisks indicate significant
difference between pump without ATA (filled diamonds) and
pump with ATA (open squares). For femoral resistance, the dif-
ferences between pumping without ATA and the other two
conditions were significant at all time points.
aggregation at the stop of pump perfusion indicates that
the aggregates did not recirculate. They probably dis-
aggregated because the number of platelets after 2
hours of pumping was not decreased: 1090 ± 179 after
versus 1054 ± 148 × 109/L before pumping (n = 7).
Also in the autoperfusion experiments, platelet count
remained at its initial level. With an uncoated tube, the
counts before and after 2 hours of perfusion were 890
± 180 and 872 ± 183 × 109/L, respectively (n = 9). With
a coated tube, these numbers were 772 ± 210 and 774
± 213 × 109/L, respectively (n = 9).
Inhibition of pump-induced platelet aggregation.
To further validate the role of platelet aggregation in
eliciting the vasodilation in the leg, another group of
rats (group 5, n = 7) received ATA, a specific inhibitor
of shear stress–induced platelet aggregation. Fig 5
(right panel) shows that the start of pump perfusion
after administration of ATA did not evoke aggregation
of platelets and did not lower femoral resistance, as
judged from the unchanged femoral pressure and flow.
Instead, femoral resistance slowly increased to an aver-
age of about 118% of its control level (Fig 3, squares).
Fig 3 also shows that ATA prevented the immediate fall
of aortic pressure. Its mean values were similar to or
even higher than those found in the experiments with
coated tubes in which no pump was used. The absence
of pump-induced platelet aggregation after administra-
tion of ATA is quantitatively shown in Fig 6 (squares).
Platelet aggregation reappeared when, after 2 to 2.5
hours, the effect of ATA waned.
A contribution of pump-induced hemolysis to the
aggregation of platelets seems unlikely because the
mean change in plasma-free hemoglobin after 2 hours
of pump perfusion was only an increase of 2.38 ± 4.97
mg/dL (n = 7). This value is small compared with the
values of 26 to 82 mg/dL found in clinical cardiopul-
monary bypass studies.18,19
Discussion
Perfusion of the rat hind leg through an uncoated
tube between the carotid and femoral arteries caused a
slow but pronounced fall in femoral resistance and aor-
tic pressure and increased the water content of the
lungs. Coating the tube with albumin largely prevented
these effects, but femoral resistance and aortic pressure
fell again as soon as the coated tube was placed in a
roller pump. This was accompanied by strong aggrega-
tion of platelets in the tube distal to the pump and could
be prevented by inhibiting platelet aggregation with a
substance that blocked the binding of von Willebrand
factor to the platelet glycoprotein Ib receptors.
Although during cardiopulmonary bypass blood may
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aggregation that diminished after 2 to 3 minutes but
remained present at a lower level for the duration of
pump perfusion. The mean aggregate formation during
the first 10 minutes is indicated in Fig 6 (diamonds).
Fig 5 also illustrates the effect of pump perfusion on
femoral pressure. Because the pump was instanta-
neously adjusted to make flow equal to the mean spon-
taneous flow, the fall of femoral pressure indicated a
fall of femoral vascular resistance.
Return from pump perfusion to autoperfusion
stopped the aggregation, but femoral resistance did not
recover. Restart of the pump again elicited some
platelet aggregation, but this did not now influence
femoral resistance. The disappearance of platelet
Fig 4. Water content in lungs (upper panel) and gastrocne-
mius muscle of the left and right leg (lower panel) after 2
hours of perfusion with an uncoated or an albumin-coated
tube. The group with a coated tube consists of experiments
with tube only (filled triangles) and experiments with tube
plus pump (filled circles). Presented are the individual values
and the median. The difference in lung water content between
the uncoated tube and no tube is significant (P = .02). In the
legs the water content is somewhat lower (P = .001) in the
tube-perfused left leg than in the right leg.
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be activated in various ways, our study first demon-
strates that the mere contact of blood with uncoated
tubing is sufficient to cause a gradual fall of aortic pres-
sure and development of lung edema. The pressure
drop was at least partially the result of vasodilation
because femoral resistance decreased in a similar way.
Second, our study shows that the benefit of coating is
reduced when a roller pump is used. Pumping resulted
in an immediate fall of aortic pressure and femoral
resistance. This was obviously caused by platelet
aggregation because at the same time many platelet
aggregates appeared in the tube section distal to the
pump, and the fall of aortic pressure and femoral resis-
tance was prevented when platelet aggregation was
inhibited. A role for platelets in pump-induced vasodi-
lation was suggested earlier by our results obtained in
cats: the vasodilation caused by pump perfusion was
absent after inhibition of platelet aggregation with
indomethacin (INN: indometacin).20
The prevention of pump-induced platelet aggregation
with ATA in the present experiments indicates that the
aggregation must have been elicited by elevated shear
stresses. Such aggregation is mediated by binding of
large multimers of the von Willebrand factor to platelet
membrane glycoprotein Ib receptors.21,22 ATA inhibits
this binding by attaching to the large von Willebrand
factor multimers but not to platelets, so that their meta-
bolic function is preserved and their reaction to adeno-
sine diphosphate and arachidonic acid, for example, is
not affected.21,23 In one experiment we corroborated
the role of shear stress by blocking the von Willebrand
Fig 5. Effect of autoperfusion and pump perfusion in a coated tube on platelet aggregation, femoral pressure
(Pfem) and flow (Ffem), and aortic pressure (Pao) in control animals (left panel) and animals after administration of
ATA (right panel). Pump flow was started at the place indicated by the arrow and set equal to the mean sponta-
neous flow. Aggregation indicates a record of raw signals from the device that measures passage of platelet aggre-
gates in tubing. The amount of aggregation is expressed as the percentage of the value found after injection of 2
ng of adenosine diphosphate into tubing.
Fig 6. Increase in amount of platelet aggregation during
pump perfusion in an albumin-coated tube (filled diamonds,
n = 7) and its prevention with ATA (filled squares, n = 7).
Values are presented as means ± SEM.
factor–platelet membrane glycoprotein Ib interaction
with VCL, a recombinant fragment of von Willebrand
factor.24 Like ATA, this substance largely prevented
platelet aggregation and the fall of femoral resistance
and aortic pressure during pumping. Moreover, unlike
ATA (Fig 3), VCL had no effect on baseline resistance.
This makes it improbable that the prevention of pump-
induced vasodilation by ATA was due to elevation of
baseline resistance instead of inhibition of platelet
aggregation. The same is indicated by our previous
experiments, in which platelet aggregation was inhibit-
ed by indomethacin, which prevented pump-induced
vasodilation without affecting baseline resistance.20
Return from pump perfusion to autoperfusion
stopped the passage of aggregates in the tube. This
indicates that the aggregates did not recirculate. The
fall of femoral resistance during platelet aggregation
makes it at the same time improbable that they were
permanently trapped in the microvessels of the leg.
They more likely disaggregated after their arrival in the
microvasculature.25 This could explain why in the pre-
sent in vivo experiments the platelet count in the circu-
lation was not lowered after 2 hours of perfusion,
although it was in a recent in vitro study,14 in which the
blood recirculated through a reservoir.
Our study indicates that the immediate fall of blood
pressure after the start of pump perfusion is caused by
platelet aggregation. We did not investigate the cause of
the more gradual decline of blood pressure during
autoperfusion with uncoated tubing. It is unlikely that
this was caused by local limb ischemia or tissue hypox-
ia because tube flow to the perfused leg amounted to
about 85% of native femoral artery flow (Fig 2), and
collateral flow is well developed in rats. In addition,
flow changes over time were similar in the autoper-
fused groups, irrespective of whether hypotension
developed. The hypotension during autoperfusion with
an uncoated tube might have resulted from activation of
blood components other than platelets (eg, related to an
inflammatory reaction).
Use of an uncoated circuit caused edema in the lung
but not in the gastrocnemius muscle of the cannulated
leg. This makes it less likely that the observed increase
of lung water content was predominantly caused by a
decrease of blood oncotic pressure. Moreover, the
amount of hypo-oncotic priming solution in our exper-
iments was small in relation to blood volume (2%-3%).
Therefore, beside changes in lymph drainage, other
components of the Starling equation may be responsi-
ble: changes in pulmonary capillary pressure, capillary
surface area, reflection coefficient, or hydraulic con-
ductivity. Which of these components is actually affect-
ed needs further investigation. Platelets do not seem to
be involved because pump perfusion caused platelet
aggregation but did not seem to increase water content
in legs and lungs, despite its pronounced effect on vas-
cular tone. This is surprising given the possibility of
platelets eliciting vascular leakage through release of
serotonin and histamine.26
Our results can partially explain the hypotension and
low systemic vascular resistance often observed in
patients undergoing cardiopulmonary bypass and
hemodialysis.1,3,4 When uncoated systems are used,
hypotension may ensue both from blood-material con-
tact and from use of a pump, which is indispensable in
such systems; when coated circuits are used, hypoten-
sion may still be caused by pump perfusion. In our
experiments with perfusion of one femoral bed, the
decrease of aortic pressure was only significant for the
first 5 minutes after the start of the pump. Presumably,
the pressure drop will last longer when more vascular
beds are involved in the vasodilatory reaction, as in car-
diopulmonary bypass. In conscious patients, as during
hemodialysis, the baroreflex and other regulating sys-
tems will correct pressure changes caused by the
release of a vasodilator. In anesthetized or conscious
patients with autonomic dysfunction, however, these
systems might not be adequate to compensate for the
continuous challenge to blood pressure.
In conclusion, vasoactive mediators generated by
blood-material contact can induce vasodilation and
lung edema, whereas agents released from platelets
activated by pumping may cause vasodilation but not
edema. Albumin coating of the tubes and blocking the
binding of von Willebrand factor to platelet glycopro-
tein Ib receptors prevent these unwanted side effects of
extracorporeal circulation.
We thank J. P. Versluis, MSc, for the measurement of lung
water content.
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